News
About half of patients with asthma on tezepelumab had discontinued their daily maintenance oral corticosteroid doses by 52 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback